Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Japan ETF (EWJ) vs Cassava Sciences Inc (FLNA) Price & Performance

iShares MSCI Japan ETFTrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Japan ETF vs Cassava Sciences Inc — how do they compare? iShares MSCI Japan ETF trades at $98.14, while Cassava Sciences Inc trades at $0.94 (market cap $47.75M). The key difference: iShares MSCI Japan ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

EWJFLNA
Sector
Broad Market / FactorHealth
52-Week High
$96.97$4.64
52-Week Low
$77.93$0.87
Market Cap
$47.75M
Enterprise Value
-$34.93M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Japan ETF

EWJ (iShares MSCI Japan ETF) trades at $98.12, up 2.16% with strong bullish technical signals from moving averages. The ETF benefits from recent U.S.-Japan currency intervention supporting the yen, while facing headwinds from Japan's inflation dynamics and export pressures. Technical indicators show overbought conditions with RSI at 84.79, suggesting potential near-term consolidation.

Outlook remains cautiously optimistic as Japanese equities respond to policy support, though currency volatility and economic uncertainty present risks. The fund's exposure to Japan's export sector faces challenges from yen strength, while domestic stimulus measures could provide upside potential for consumer-focused holdings.

Cassava Sciences Inc

FLNA trades at $0.9973, up 0.23% with a bearish technical signal despite recent earnings beats. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though cash burn improved from -$33M to -$30M projected for 2026. Analyst consensus is strongly bullish with 8 buy ratings versus 4 hold ratings.

The outlook remains challenging due to persistent losses and negative cash flow, but analyst optimism and continued progress in TSC-related epilepsy therapies provide potential catalysts. Key risks include execution challenges in clinical development and the company's ability to secure additional funding.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Japan ETF

EWJ tracks the MSCI Japan Index, providing broad exposure to over 180 large and mid-cap companies in Japan. It is the most established and liquid vehicle for accessing the Japanese equity market, featuring a diversified portfolio across industrials, consumer discretionary, and financial sectors.

Read more on EWJ

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA